content

Gene-Edited Neutrophils Show Potential Against Lung Cancer

In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related...

Vetter again demonstrates industry leadership in sustainability initiatives

Report now includes Scope 3 emissions Employee-driven social responsibility takes precedence as driving force for sustainability activities Goal to reduce total emissions globally...

Telix Opens $21.2M European Radiopharmaceutical Production Facility

Telix Pharmaceuticals Limited opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility located in Belgium. The 2,800 square meter facility is one of Europe's largest...

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Charles River Laboratories International, Inc. and the INADcure Foundation, a nonprofit organization whose mission is to support the development of treatments for Infantile Neuroaxonal...

Quell Therapeutics, AstraZeneca Partner on Engineered Treg Cell Therapies

Quell Therapeutics Ltd, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced that it...

Pharma Dealmaking Recovery Gets Boosted By $85bn M&A Splurge

It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which...

Lack of Experience Hinders CDMOs In Cell And Gene Therapy

CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read